Purpose: Contrast enhancement (CE) after mechanical thrombectomy (MT) remains a subject of investigation, with a reported prevalence ranging from 31 to 88%. We examined our patients to identify predictors of CE and its impact on outcomes, an aspect that remains understudied.
Methods: We retrospectively analyzed 106 patients who underwent MT at our hospital between 2018 and 2022.